Mesalazine dose modification based on faecal calprotectin levels in patients with ulcerative colitis in clinical remission Gisela Piñero; Míriam Mañosa; Margalida Calafat; Eva Vayreda; Fiorella Cañete; Maria Puig; Eugeni Domènech;

Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease Francisco Guilherme Cancela Penna; Rodrigo Macedo Rosa; Fernando H. Pereira; Pedro Ferrari Sales Cunha; Stella Cristina S. Sousa; Teresa Cristina A. Ferrari; Carlos Cara; Maria de Lourdes A. Ferrari;

Limitations of the determination of faecal calprotectin in patients with ulcerative colitis and inflammatory polyps Fernando Bermejo; Alicia Algaba; Daniel Bonillo; Laura Jiménez; Antonio Guardiola-Arévalo; María Pacheco; Ángel Castaño; Iván Guerra;